Growth Metrics

Scotts Miracle-Gro (SMG) Common Equity (2016 - 2025)

Scotts Miracle-Gro's Common Equity history spans 17 years, with the latest figure at -$500.6 million for Q4 2025.

  • For Q4 2025, Common Equity fell 4.4% year-over-year to -$500.6 million; the TTM value through Dec 2025 reached -$500.6 million, down 4.4%, while the annual FY2025 figure was -$357.5 million, 8.47% up from the prior year.
  • Common Equity for Q4 2025 was -$500.6 million at Scotts Miracle-Gro, down from -$357.5 million in the prior quarter.
  • Across five years, Common Equity topped out at $1.1 billion in Q3 2021 and bottomed at -$500.6 million in Q4 2025.
  • The 5-year median for Common Equity is $59.5 million (2022), against an average of $153.4 million.
  • The largest annual shift saw Common Equity surged 44.16% in 2021 before it tumbled 747.73% in 2023.
  • A 5-year view of Common Equity shows it stood at $1.0 billion in 2021, then tumbled by 94.13% to $59.5 million in 2022, then crashed by 747.73% to -$385.4 million in 2023, then fell by 24.42% to -$479.5 million in 2024, then dropped by 4.4% to -$500.6 million in 2025.
  • Per Business Quant, the three most recent readings for SMG's Common Equity are -$500.6 million (Q4 2025), -$357.5 million (Q3 2025), and -$170.9 million (Q2 2025).